January 9, 2018 | Daily JAM, Morning Briefing, NKTR, Stock Alerts |
Anybody still think that conferences, especially biotech conferences, don’t move stock prices? Shares of Nektar Therapeutics (NKTR) are up 7.65% today to $61.79 as of noon New York time on the company’s appearance at this week’s J.P. Morgan biotech conference. The slides from the company’s presentation today are in circulation but CEO Howard Robin doesn’t actually present until 2 p.m. New York time today.
December 18, 2017 | Daily JAM, NKTR, Stock Alerts |
No point in hoping that Nektar Therapeutics (NKTR) will match this year's gain of 364% as of the close on December 18. But I think the stock could easily climb another 30% or more in 2018 as the company de-risks its very promising drug candidates in the opioid and...
November 13, 2017 | Daily JAM, NKTR, Stock Alerts |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
November 13, 2017 | Daily JAM, NKTR, Stock Alerts, Volatility |
Shares of Nektar Therapeutics (NKTR) are up another 16% this morning to $37.89 as of noon New York time on data presented this weekend at the annual meeting of the Society for Immunotherapy of Cancer from an early trial of Nektar's NKTR-214. The data looked at the...
November 9, 2017 | Daily JAM, NKTR, Stock Alerts, Volatility |
On the evening of October 31 I wrote that a decision onwhat to do with the Netkar Therapeutics options (NKTR180119C00022000)--the January 19, 2018 call at $22--that I added to my Volatility Portfolio back on May 16, 2017 at a price of $2.64 (the closing options price...
October 31, 2017 | Daily JAM, NKTR, Stock Alerts |
This is a tough one. A very tough one. I added Netkar options (NKTR180119C00022000)--the January 19, 2018 call at $22--to my volatility portfolio back on May 16, 2017 at a price of $2.64 (the closing options price on that day.) Â Today, using the last price again on...
August 22, 2017 | Daily JAM, NKTR, Stock Alerts |
Biotechs--and indeed any high price-to-earnings stocks perceived as risky--have taken more than their share of punishment in the nervous sell off of the last few weeks. Nektar Therapeutics (NKTR), for example, closed yesterday August 21 at $17.79. That's down from...
August 8, 2017 | Daily JAM, NKTR, Stock Alerts |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
May 16, 2017 | Daily JAM, NKTR, Stock Alerts |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
March 20, 2017 | Daily JAM, NKTR, Stock Alerts, Volatility |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
March 6, 2017 | Daily JAM, NKTR, Volatility |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
